Resective surgery to treat refractory status epilepticus in children with focal epileptogenesis
Authors:
- 8 February 2005
- journal article
- review article
- Published by Wolters Kluwer Health in Neurology
- Vol. 64 (3) , 567-570
Abstract
Prolonged high-dose suppressive therapy (HDST) is a mainstay in the management of refractory status epilepticus (RSE), albeit with high morbidity and mortality. The authors studied 10 patients who were carefully selected for epilepsy surgery after failing prolonged (>2 weeks) HDST. Status epilepticus was stopped acutely in all of them with no mortality and no substantial morbidity. At follow-up (median 7 months), 7 (70%) of 10 patients were seizure free, and 3 (30%) of 10 had significant improvement in their epilepsy.Keywords
This publication has 9 references indexed in Scilit:
- Prolonged treatment for acute symptomatic refractory status epilepticusNeurology, 2003
- Treatment of Refractory Status Epilepticus with Pentobarbital, Propofol, or Midazolam: A Systematic ReviewEpilepsia, 2002
- Outcome of Severe Refractory Status Epilepticus in ChildrenEpilepsia, 2001
- Neurologic outcomes of pediatric epileptic patients with pentobarbital comaPediatric Neurology, 2001
- Neurosurgical treatment of medically intractable status epilepticusEpilepsy Research, 2001
- Vagal Nerve Stimulation for Status epilepticusPediatric Neurosurgery, 2001
- Efficacy and Mortality in Treatment of Refractory Generalized Convulsive Status Epilepticus in Children: A Meta-AnalysisJournal of Child Neurology, 1999
- Advances in the management of refractory status epilepticusCritical Care Medicine, 1993
- Life-Threatening Focal Status Epilepticus due to Occult Cortical DysplasiaArchives of Neurology, 1993